| Symbol |
Name |
Standardized Value |
|
SYP
|
synaptophysin
|
2.912
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
2.803
|
|
CD99
|
CD99 molecule
|
2.751
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
2.675
|
|
CD99L2
|
CD99 molecule-like 2
|
2.584
|
|
CHGA
|
chromogranin A
|
2.391
|
|
EWSR1
|
EWS RNA-binding protein 1
|
2.323
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
2.306
|
|
NCAM1
|
neural cell adhesion molecule 1
|
2.273
|
|
AVP
|
arginine vasopressin
|
2.133
|
|
NKX2-2
|
NK2 homeobox 2
|
2.095
|
|
POMC
|
proopiomelanocortin
|
2.055
|
|
OMP
|
olfactory marker protein
|
1.933
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.927
|
|
MYOG
|
myogenin (myogenic factor 4)
|
1.861
|
|
KRT7
|
keratin 7, type II
|
1.834
|
|
SSTR2
|
somatostatin receptor 2
|
1.833
|
|
OTX1
|
orthodenticle homeobox 1
|
1.808
|
|
PHOX2B
|
paired-like homeobox 2b
|
1.802
|
|
SST
|
somatostatin
|
1.797
|
|
CALB2
|
calbindin 2
|
1.794
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.787
|
|
GFAP
|
glial fibrillary acidic protein
|
1.777
|
|
KRT5
|
keratin 5, type II
|
1.763
|
|
INSM1
|
insulinoma-associated 1
|
1.761
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.728
|
|
KRT20
|
keratin 20, type I
|
1.716
|
|
TP63
|
tumor protein p63
|
1.683
|
|
TUBB3
|
tubulin, beta 3 class III
|
1.669
|
|
NKX2-1
|
NK2 homeobox 1
|
1.628
|
|
TBX19
|
T-box 19
|
1.598
|
|
TP53
|
tumor protein p53
|
1.598
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
1.595
|
|
PRAMEF17
|
PRAME family member 17
|
1.568
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
1.525
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.517
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.495
|
|
OTX2
|
orthodenticle homeobox 2
|
1.476
|
|
KRT8
|
keratin 8, type II
|
1.467
|
|
LCN15
|
lipocalin 15
|
1.457
|
|
SATB2
|
SATB homeobox 2
|
1.449
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.434
|
|
WT1
|
Wilms tumor 1
|
1.418
|
|
CRH
|
corticotropin releasing hormone
|
1.415
|
|
C6ORF47
|
chromosome 6 open reading frame 47
|
1.389
|
|
CD274
|
CD274 molecule
|
1.386
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.385
|
|
CCNB3
|
cyclin B3
|
1.382
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
1.37
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
1.359
|
|
CDX2
|
caudal type homeobox 2
|
1.359
|
|
FSD1L
|
fibronectin type III and SPRY domain containing 1-like
|
1.355
|
|
TH
|
tyrosine hydroxylase
|
1.331
|
|
TYR
|
tyrosinase
|
1.33
|
|
DUX4
|
double homeobox 4
|
1.33
|
|
MYOD1
|
myogenic differentiation 1
|
1.329
|
|
NSD3
|
nuclear receptor binding SET domain protein 3
|
1.328
|
|
CD34
|
CD34 molecule
|
1.325
|
|
GATA3
|
GATA binding protein 3
|
1.313
|
|
SALL4
|
spalt-like transcription factor 4
|
1.312
|
|
EGFR
|
epidermal growth factor receptor
|
1.28
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.28
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
1.276
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.267
|
|
CNGA2
|
cyclic nucleotide gated channel alpha 2
|
1.266
|
|
PWWP2A
|
PWWP domain containing 2A
|
1.259
|
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|
1.259
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
1.258
|
|
PRL
|
prolactin
|
1.257
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.256
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.256
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.256
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.236
|
|
NF1
|
neurofibromin 1
|
1.216
|
|
NEUROD1
|
neuronal differentiation 1
|
1.211
|
|
ASCL3
|
achaete-scute family bHLH transcription factor 3
|
1.207
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
1.2
|
|
RET
|
ret proto-oncogene
|
1.189
|
|
AFF2
|
AF4/FMR2 family, member 2
|
1.188
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.187
|
|
ZNF532
|
zinc finger protein 532
|
1.186
|
|
CD8A
|
CD8a molecule
|
1.18
|
|
SHH
|
sonic hedgehog
|
1.176
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.169
|
|
NSMAF
|
neutral sphingomyelinase (N-SMase) activation associated factor
|
1.165
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.163
|
|
BRD4
|
bromodomain containing 4
|
1.158
|
|
OR51E1
|
olfactory receptor, family 51, subfamily E, member 1
|
1.15
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.149
|
|
PAX7
|
paired box 7
|
1.148
|
|
POU2F3
|
POU class 2 homeobox 3
|
1.137
|
|
OR10G4
|
olfactory receptor, family 10, subfamily G, member 4
|
1.133
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
1.122
|
|
ISL1
|
ISL LIM homeobox 1
|
1.117
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.113
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.113
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.103
|
|
KDR
|
kinase insert domain receptor
|
1.1
|
|
LAMA2
|
laminin, alpha 2
|
1.098
|
|
KRT19
|
keratin 19, type I
|
1.094
|
|
ETV4
|
ets variant 4
|
1.094
|
|
NKX3-1
|
NK3 homeobox 1
|
1.093
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.093
|
|
CCND1
|
cyclin D1
|
1.091
|
|
PAX3
|
paired box 3
|
1.086
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
1.085
|
|
BRD3
|
bromodomain containing 3
|
1.081
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.078
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.075
|
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1
|
1.075
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.069
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
1.067
|
|
TERT
|
telomerase reverse transcriptase
|
1.054
|
|
DEK
|
DEK proto-oncogene
|
1.042
|
|
MAP2
|
microtubule-associated protein 2
|
1.039
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.038
|
|
SSTR5
|
somatostatin receptor 5
|
1.022
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
1.021
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.021
|
|
CD68
|
CD68 molecule
|
1.018
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
1.013
|
